Healthcare technology shifts toward AI evidence and neutral data standards

The healthcare technology sector is seeing significant shifts toward AI-driven evidence retrieval and vendor-neutral data architectures. OpenEvidence, valued at $12 billion as of January 2026, has emerged as a major clinical tool. The platform provides rapid access to peer-reviewed medical literature, with reports indicating that over 40% of U.S. physicians have signed up. The company handles approximately 30 million questions monthly and is utilized across more than 10,000 hospitals and medical centers.

Simultaneously, there is growing global momentum for openEHR, a standard for durable, vendor-neutral clinical data. According to Black Book Research, interest in openEHR is driven by the need for AI-usable longitudinal clinical records and digital sovereignty. This shift reflects a move toward procurement strategies that prioritize data that outlives specific applications. To support this expansion, openEHR International has expanded its team with new experts in clinical modelling and informatics.